HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MONOCYTE-DERIVED MACROPHAGES EXPRESS SURFACE GP120 AND FUSE WITH CD4 LYMPHOID-CELLS INVITRO - A POSSIBLE MECHANISM OF LYMPHOCYTE-T DEPLETION INVIVO

被引:25
作者
CROWE, SM
MILLS, J
ELBEIK, T
LIFSON, JD
KOSEK, J
MARSHALL, JA
ENGLEMAN, EG
MCGRATH, MS
机构
[1] GENELABS INC,DIV CELLULAR IMMUNOL,REDWOOD CITY,CA 94063
[2] FAIRFIELD HOSP,MELBOURNE,VIC 3078,AUSTRALIA
[3] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT MED,MED SERV,SAN FRANCISCO,CA 94110
[4] UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,DEPT MICROBIOL,SAN FRANCISCO,CA 94110
[5] STANFORD UNIV,MED CTR,SCH MED,DEPT PATHOL,STANFORD,CA 94305
[6] MACFARLANE BURNET CTR MED RES,MELBOURNE,VIC,AUSTRALIA
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1992年 / 65卷 / 02期
关键词
D O I
10.1016/0090-1229(92)90217-C
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Monocyte-derived macrophages (MDM) infected in vitro with a macrophage-tropic strain of human immunodeficiency virus (HIV) fused with uninfected, CD4-expressing T lymphoblastoid cells, but not with a subclone of these cells lacking surface CD4. Infected MDM also fused with uninfected autologous and heterologous MDM. Recombinant soluble CD4 protein (rsCD4) (10 μg/ml) and full-length recombinant glycosylated gp120 (20 μg/ml) each inhibited fusion by 94-99%; the inhibition was dose-dependent. The N-terminal portion of gp120 did not inhibit syncytium formation. Fusion was also inhibited by a monoclonal antibody to an epitope which binds gp120 (S3.5), but not by antibody to an epitope not involved in gp120 binding (OKT4). HIV-infected MDM specifically bound fluorescein-conjugated rsCD4, and virus could be visualized budding from the surface of these cells. HIV-infected MDM express viral gp120 on their surface and fuse with CD4-bearing cells in a fashion similar to lymphoid cells. Macrophages may contribute to CD4 lymphocyte depletion in vivo by this fusion mechanism. © 1992.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 39 条
[1]   CD4 IS RETAINED IN THE ENDOPLASMIC-RETICULUM BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN PRECURSOR [J].
CRISE, B ;
BUONOCORE, L ;
ROSE, JK .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5585-5593
[2]   FULL-LENGTH RECOMBINANT CD4 AND RECOMBINANT GP120 INHIBIT FUSION BETWEEN HIV INFECTED MACROPHAGES AND UNINFECTED CD4-EXPRESSING T-LYMPHOBLASTOID CELLS [J].
CROWE, SM ;
MILLS, J ;
KIRIHARA, J ;
BOOTHMAN, J ;
MARSHALL, JA ;
MCGRATH, MS .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1990, 6 (08) :1031-1037
[3]  
CROWE SM, 1987, AIDS RES HUM RETROV, V3, P134
[4]   A SOLUBLE FORM OF CD4 (T4) PROTEIN INHIBITS AIDS VIRUS-INFECTION [J].
DEEN, KC ;
MCDOUGAL, JS ;
INACKER, R ;
FOLENAWASSERMAN, G ;
ARTHOS, J ;
ROSENBERG, J ;
MADDON, PJ ;
AXEL, R ;
SWEET, RW .
NATURE, 1988, 331 (6151) :82-84
[5]  
DIAMOND DC, 1988, J IMMUNOL, V141, P3715
[6]   EFFECTS OF SELECTIVE DEPLETION OF L3T4+ LYMPHOCYTES-T ON HERPES-SIMPLEX VIRUS ENCEPHALITIS [J].
ERLICH, KS ;
WOFSY, D ;
DIX, RD ;
MILLS, J .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1989, 52 (02) :190-201
[7]   INVIVO ACTIVATION OF CD4+ CELLS IN AIDS [J].
FUCHS, D ;
HAUSEN, A ;
HENGSTER, P ;
REIBNEGGER, G ;
SCHULZ, T ;
WERNER, ER ;
DIERICH, MP ;
WACHTER, H .
SCIENCE, 1987, 235 (4786) :356-356
[8]   THE ROLE OF MONONUCLEAR PHAGOCYTES IN HTLV-III LAV INFECTION [J].
GARTNER, S ;
MARKOVITS, P ;
MARKOVITZ, DM ;
KAPLAN, MH ;
GALLO, RC ;
POPOVIC, M .
SCIENCE, 1986, 233 (4760) :215-219
[9]   IMMUNOPATHOGENESIS OF HUMAN IMMUNODEFICIENCY VIRUS-INFECTION IN THE CENTRAL NERVOUS-SYSTEM [J].
GENDELMAN, HE ;
LEONARD, JM ;
DUTKO, FJ ;
KOENIG, S ;
KHILLAN, JS ;
MELTZER, MS .
ANNALS OF NEUROLOGY, 1988, 23 :S78-S81
[10]   EFFICIENT ISOLATION AND PROPAGATION OF HUMAN IMMUNODEFICIENCY VIRUS ON RECOMBINANT COLONY-STIMULATING FACTOR-1-TREATED MONOCYTES [J].
GENDELMAN, HE ;
ORENSTEIN, JM ;
MARTIN, MA ;
FERRUA, C ;
MITRA, R ;
PHIPPS, T ;
WAHL, LA ;
LANE, HC ;
FAUCI, AS ;
BURKE, DS ;
SKILLMAN, D ;
MELTZER, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1428-1441